ACRBP | Acrosin binding protein | Predicted secreted proteins
| | ![](/images/39082/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/39082/85218_B_8_8_rna_selected_60x60.jpg) | Tissue enriched |
ACRC | Acidic repeat containing | | ![](/images/23476/ihc_selected_60x60.jpg) | ![](/images/23476/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/23476/53363_A_2_3_rna_selected_60x60.jpg) | Tissue enhanced |
ACRV1 | Acrosomal vesicle protein 1 | Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/38718/80041_B_8_1_rna_selected_60x60.jpg) | Tissue enriched |
ACSBG1 | Acyl-CoA synthetase bubblegum family member 1 | Enzymes
| ![](/images/45955/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/45955/110480_B_5_1_rna_selected_60x60.jpg) | Tissue enhanced |
ACSBG2 | Acyl-CoA synthetase bubblegum family member 2 | Enzymes Predicted membrane proteins
| | ![](/images/43421/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/51013/138568_B_9_4_rna_selected_60x60.jpg) | Tissue enriched |
ACSL6 | Acyl-CoA synthetase long-chain family member 6 | Cancer-related genes Disease related genes Enzymes Mitochondrial proteins Potential drug targets Predicted membrane proteins
| ![](/images/40470/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/40470/87248_B_8_1_rna_selected_60x60.jpg) | Tissue enhanced |
ACSM1 | Acyl-CoA synthetase medium-chain family member 1 | Enzymes Mitochondrial proteins Predicted membrane proteins
| ![](/images/46291/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images/46291/ihc_cell_selected_60x60.jpg) | ![](/images/46291/102059_B_8_3_rna_selected_60x60.jpg) | Tissue enhanced |
ACSM2A | Acyl-CoA synthetase medium-chain family member 2A | Enzymes Mitochondrial proteins Predicted membrane proteins
| ![](/images/57699/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/57699/133710_A_8_2_rna_selected_60x60.jpg) | Group enriched |
ACSM2B | Acyl-CoA synthetase medium-chain family member 2B | Enzymes Mitochondrial proteins Predicted membrane proteins
| ![](/images/57699/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/57699/133710_A_8_2_rna_selected_60x60.jpg) | Group enriched |
ACSM3 | Acyl-CoA synthetase medium-chain family member 3 | Enzymes Mitochondrial proteins
| ![](/images/41013/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/41013/84762_B_9_3_rna_selected_60x60.jpg) | Tissue enhanced |
ACSM5 | Acyl-CoA synthetase medium-chain family member 5 | Enzymes Mitochondrial proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/41435/96461_B_8_1_rna_selected_60x60.jpg) | Tissue enriched |
ACTA1 | Actin, alpha 1, skeletal muscle | Cytoskeleton related proteins Disease related genes Plasma proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/45/370_B_8_6_rna_selected_60x60.jpg) | Tissue enriched |
ACTC1 | Actin, alpha, cardiac muscle 1 | Disease related genes Plasma proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/37330/73558_B_9_1_rna_selected_60x60.jpg) | Tissue enriched |
ACTG2 | Actin, gamma 2, smooth muscle, enteric | Cytoskeleton related proteins
| ![](/images/41264/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/41271/103141_B_8_2_rna_selected_60x60.jpg) | Tissue enhanced |
ACTL10 | Actin-like 10 | Predicted secreted proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enriched |
ACTL6B | Actin-like 6B | | ![](/images/45126/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/45126/103837_B_9_2_rna_selected_60x60.jpg) | Tissue enriched |
ACTL7A | Actin-like 7A | Cytoskeleton related proteins
| | | ![](/images/21624/ihc_cell_selected_60x60.jpg) | ![](/images/21624/49060_B_9_7_rna_selected_60x60.jpg) | Tissue enriched |
ACTL7B | Actin-like 7B | | | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/21803/48741_A_3_3_rna_selected_60x60.jpg) | Tissue enriched |
ACTL8 | Actin-like 8 | Cytoskeleton related proteins
| ![](/images/27176/ihc_selected_60x60.jpg) | ![](/images/27176/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/27176/57476_B_8_1_rna_selected_60x60.jpg) | Tissue enriched |
ACTL9 | Actin-like 9 | Cytoskeleton related proteins
| ![](/images/26693/ihc_selected_60x60.jpg) | ![](/images/19231/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/26693/55425_A_3_5_rna_selected_60x60.jpg) | Tissue enriched |
ACTN2 | Actinin, alpha 2 | Cytoskeleton related proteins Disease related genes Plasma proteins
| ![](/images/8315/ihc_selected_60x60.jpg) | ![](/images/6035/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/8315/22377_B_8_5_rna_selected_60x60.jpg) | Group enriched |
ACTRT1 | Actin-related protein T1 | Cytoskeleton related proteins
| ![](/images/3119/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images/3119/ihc_cell_selected_60x60.jpg) | ![](/images/3119/8917_B_9_4_rna_selected_60x60.jpg) | Tissue enriched |
ACTRT2 | Actin-related protein T2 | Cytoskeleton related proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/6480/142257_B_8_1_rna_selected_60x60.jpg) | Tissue enriched |
ACTRT3 | Actin-related protein T3 | Cytoskeleton related proteins
| ![](/images/35818/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/35818/142138_B_1_6_rna_selected_60x60.jpg) | Tissue enriched |
ACVR1C | Activin A receptor, type IC | Enzymes Predicted membrane proteins Predicted secreted proteins
| ![](/images/11933/ihc_selected_60x60.jpg) | ![](/images/7982/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/11933/28615_B_1_7_rna_selected_60x60.jpg) | Tissue enriched |
ACY1 | Aminoacylase 1 | Disease related genes Enzymes Plasma proteins Potential drug targets
| | ![](/images/36175/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/36174/98822_B_8_3_rna_selected_60x60.jpg) | Group enriched |
ACY3 | Aspartoacylase (aminocyclase) 3 | Enzymes
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/39219/83702_B_9_3_rna_selected_60x60.jpg) | Tissue enhanced |
ADA | Adenosine deaminase | Disease related genes Enzymes FDA approved drug targets Plasma proteins
| | | ![](/images/4307/ihc_cell_selected_60x60.jpg) | ![](/images/23884/54930_B_9_3_rna_selected_60x60.jpg) | Tissue enriched |
ADAD1 | Adenosine deaminase domain containing 1 (testis-specific) | | ![](/images/44080/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/44080/97838_B_8_3_rna_selected_60x60.jpg) | Tissue enriched |
ADAD2 | Adenosine deaminase domain containing 2 | | ![](/images/43994/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/43994/98650_B_7_7_rna_selected_60x60.jpg) | Tissue enriched |
ADAM11 | ADAM metallopeptidase domain 11 | Enzymes Predicted membrane proteins Predicted secreted proteins
| ![](/images_static/rna_center.gif) | ![](/images/53299/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
ADAM12 | ADAM metallopeptidase domain 12 | Enzymes Predicted membrane proteins Predicted secreted proteins
| | | ![](/images_static/rna_center.gif) | ![](/images/30866/72417_B_8_2_rna_selected_60x60.jpg) | Tissue enriched |
ADAM18 | ADAM metallopeptidase domain 18 | Enzymes Predicted membrane proteins Predicted secreted proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enriched |
ADAM2 | ADAM metallopeptidase domain 2 | Enzymes Predicted membrane proteins
| | ![](/images/26581/if_selected_60x60.jpg) | ![](/images/24621/ihc_cell_selected_60x60.jpg) | ![](/images/26581/55144_B_9_5_rna_selected_60x60.jpg) | Tissue enriched |
ADAM20 | ADAM metallopeptidase domain 20 | Enzymes Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/59377/144044_B_8_1_rna_selected_60x60.jpg) | Tissue enriched |
ADAM21 | ADAM metallopeptidase domain 21 | Enzymes Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images/59016/ihc_cell_selected_60x60.jpg) | ![](/images/59016/131825_B_7_8_rna_selected_60x60.jpg) | Tissue enriched |
ADAM22 | ADAM metallopeptidase domain 22 | Enzymes Predicted membrane proteins Predicted secreted proteins
| ![](/images/45282/ihc_selected_60x60.jpg) | ![](/images/45282/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/45282/99568_B_8_1_rna_selected_60x60.jpg) | Tissue enhanced |
ADAM23 | ADAM metallopeptidase domain 23 | Enzymes Predicted membrane proteins Predicted secreted proteins
| ![](/images/12130/ihc_selected_60x60.jpg) | ![](/images/33276/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/33276/64802_B_9_7_rna_selected_60x60.jpg) | Tissue enhanced |
ADAM28 | ADAM metallopeptidase domain 28 | Enzymes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
ADAM29 | ADAM metallopeptidase domain 29 | Disease related genes Enzymes Potential drug targets Predicted membrane proteins Predicted secreted proteins
| ![](/images/14159/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/14159/33284_B_8_1_rna_selected_60x60.jpg) | Tissue enriched |
ADAM30 | ADAM metallopeptidase domain 30 | Enzymes Plasma proteins Predicted membrane proteins
| ![](/images/26080/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/26080/55850_B_2_3_rna_selected_60x60.jpg) | Tissue enriched |
ADAM32 | ADAM metallopeptidase domain 32 | Enzymes Predicted membrane proteins Predicted secreted proteins
| ![](/images/44156/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/44156/96845_B_9_1_rna_selected_60x60.jpg) | Tissue enriched |
ADAM8 | ADAM metallopeptidase domain 8 | CD markers Enzymes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/64637/143728_A_5_8_rna_selected_60x60.jpg) | Tissue enhanced |
ADAMDEC1 | ADAM-like, decysin 1 | Enzymes Plasma proteins Predicted secreted proteins
| ![](/images/28317/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/28317/59556_B_8_1_rna_selected_60x60.jpg) | Tissue enhanced |
ADAMTS1 | ADAM metallopeptidase with thrombospondin type 1 motif, 1 | Cancer-related genes Enzymes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| ![](/images/16394/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/16394/36382_B_8_2_rna_selected_60x60.jpg) | Tissue enhanced |
ADAMTS13 | ADAM metallopeptidase with thrombospondin type 1 motif, 13 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted secreted proteins
| | ![](/images/42014/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/42014/98164_B_8_6_rna_selected_60x60.jpg) | Tissue enhanced |
ADAMTS14 | ADAM metallopeptidase with thrombospondin type 1 motif, 14 | Cancer-related genes Enzymes Plasma proteins Predicted secreted proteins
| ![](/images/34605/ihc_selected_60x60.jpg) | ![](/images/34605/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/34605/68654_B_9_1_rna_selected_60x60.jpg) | Tissue enhanced |
ADAMTS15 | ADAM metallopeptidase with thrombospondin type 1 motif, 15 | Enzymes Predicted secreted proteins
| ![](/images/42867/ihc_selected_60x60.jpg) | ![](/images/42867/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/42867/95746_B_9_1_rna_selected_60x60.jpg) | Tissue enhanced |
ADAMTS16 | ADAM metallopeptidase with thrombospondin type 1 motif, 16 | Enzymes Predicted secreted proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
ADAMTS18 | ADAM metallopeptidase with thrombospondin type 1 motif, 18 | Cancer-related genes Disease related genes Enzymes Potential drug targets Predicted secreted proteins
| ![](/images/44326/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/44326/104929_B_9_2_rna_selected_60x60.jpg) | Tissue enriched |